Eli Lilly and Company

Senior Director - Global Diagnostics Scientific Affairs

Chester, Maryland, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Pharmaceuticals, BiotechnologyIndustries

Job Description

Employment Type: Full time

Position Overview

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Organization Overview

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism.

Role Overview

The Director - Global Diagnostic Scientific Affairs will leverage their deep lab medicine, pathology, and diagnostic industry knowledge and scientific acumen to create clear strategic plans for addressing barriers to diagnostic accuracy and availability across the globe. In addition, this leader will function as the lab medicine expert for the enterprise, supporting diagnostic integration into training, evidence generation planning, and global diagnostic Key Opinion Leader and conference prioritization.

Responsibilities

  • Function as the subject matter expert on lab medicine across enterprise; centralized expertise on pre-analytical, analytical, and post-analytical lab processes for enterprise.
  • Deliver a global diagnostic accuracy strategy including, but not limited to, diagnostic standardization, EQA Involvement, concordance studies, and early pathology/lab training curricula, where appropriate.
  • Deliver a global diagnostic availability strategy including, but not limited to, creating regional diagnostic centers-of-excellence, and supporting test availability, where appropriate.
  • Organize and support the centralized process and management for diagnostic guideline body submissions, (e.g., CAP, ADLM, IFCC).
  • Organize and deliver input into the companion diagnostic partner selection process in diagnostic development.
  • Collect and maintain a cross-business unit view of labs/markets and their adoption of testing, technology, etc. to inform strategy and companion diagnostic partner selection.
  • Collect and disseminate insight on macro trends in diagnostic technology and support decisions on collaboration partners.
  • Guide business units in pathology and lab medicine key external expert selection for inclusion in insight generation.
  • Provide supportive diagnostic training to Lilly teams to upskill the organization.
  • Ensure best practices are faithfully cross-pollinated and integrated across business units for diagnostic-relevant Lilly sponsored studies and collaborative research.
  • Develop and maintain strong understanding of the clinical and anatomic pathology laboratory and its applications and relevance to Lilly portfolio.

Basic Requirements/Qualifications

  • Ph.D., or other relevant doctorate
  • 5 years of clinical or pharmaceutical industry experience

Additional Skills and Preferences

  • 8+ years relevant diagnostic medical affairs experience
  • Deep understanding of lab medicine
  • Outcomes Focus: Demonstrated both a bias for action and focus on results.
  • Problem Solving: Demonstrated ability to appropriately diagnose business problems and create and implement appropriate solutions.
  • Measurement Orientation: Demonstrated ability and propensity to use data, measurement and analytics to diagnose problems and to evaluate the actual effect of changes implemented.
  • Deep curiosity and drive to solve complex problems and create impactful solutions.
  • Teamwork orientation, interpersonal astuteness, and able to work within a matrix.
  • Ability to collaborate and influence across teams.

Skills

Lab Medicine
Pathology
Diagnostic Industry
Scientific Acumen
Strategic Planning
Diagnostic Accuracy
Diagnostic Availability
Diagnostic Standardization
EQA Involvement
Concordance Studies
Pre-analytical Processes
Analytical Processes
Post-analytical Processes
Key Opinion Leader Engagement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI